Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Ketteler

Showing results (41-50 of 220) with videos related to

Pageof 22
Sort By:
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|May 29, 2012
Not all phosphate is created equalMarkus Ketteler, Ralf Westenfeld, Eberhard Ritz
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 27, 2012
Impact of oral calcium on mortality of dialysis patients--an underestimated risk?Juergen Bommer, Markus Ketteler, Eberhard Ritz
Seminars in Nephrology|May 1, 2014
Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?Pieter Evenepoel, Mariano Rodriguez, Markus Ketteler
Kidney & Blood Pressure Research|September 25, 2019
Needs Around Dialysis Treatment from Different Perspectives (NADIP): Results of the Exploratory German Multicenter SurveyPatrick Biggar, Dennis Hidde, Markus Ketteler
Journal of Nephrology|February 22, 2011
Calciphylaxis: a still unmet challengeVincent M Brandenburg, Mario Cozzolino, Markus Ketteler
Trends in Cardiovascular Medicine|May 8, 2007
Vascular calcification and fetuin-A deficiency in chronic kidney diseaseRalf Westenfeld, Willi Jahnen-Dechent, Markus Ketteler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 13, 2012
FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney diseaseMarkus Ketteler, Patrick H Biggar, Orfeas Liangos
Clinical Kidney Journal|May 29, 2015
Management of hyperphosphataemia in chronic kidney disease-challenges and solutionsMarkus Ketteler, Rudolf P Wüthrich, Jürgen Floege
Expert Opinion on Pharmacotherapy|September 20, 2016
Treating hyperphosphatemia - current and advancing drugsMarkus Ketteler, Orfeas Liangos, Patrick H Biggar
Expert Opinion on Therapeutic Targets|March 20, 2020
An expert update on novel therapeutic targets for hyperphosphatemia in chronic kidney disease: preclinical and clinical innovationsMario Cozzolino, Markus Ketteler, Carsten Alexander Wagner
Pageof 22

Showing results (41-50 of 220) with videos related to

Sort By:
Pageof 22
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|May 29, 2012
Not all phosphate is created equalMarkus Ketteler, Ralf Westenfeld, Eberhard Ritz
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 27, 2012
Impact of oral calcium on mortality of dialysis patients--an underestimated risk?Juergen Bommer, Markus Ketteler, Eberhard Ritz
Seminars in Nephrology|May 1, 2014
Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?Pieter Evenepoel, Mariano Rodriguez, Markus Ketteler
Kidney & Blood Pressure Research|September 25, 2019
Needs Around Dialysis Treatment from Different Perspectives (NADIP): Results of the Exploratory German Multicenter SurveyPatrick Biggar, Dennis Hidde, Markus Ketteler
Journal of Nephrology|February 22, 2011
Calciphylaxis: a still unmet challengeVincent M Brandenburg, Mario Cozzolino, Markus Ketteler
Trends in Cardiovascular Medicine|May 8, 2007
Vascular calcification and fetuin-A deficiency in chronic kidney diseaseRalf Westenfeld, Willi Jahnen-Dechent, Markus Ketteler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 13, 2012
FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney diseaseMarkus Ketteler, Patrick H Biggar, Orfeas Liangos
Clinical Kidney Journal|May 29, 2015
Management of hyperphosphataemia in chronic kidney disease-challenges and solutionsMarkus Ketteler, Rudolf P Wüthrich, Jürgen Floege
Expert Opinion on Pharmacotherapy|September 20, 2016
Treating hyperphosphatemia - current and advancing drugsMarkus Ketteler, Orfeas Liangos, Patrick H Biggar
Expert Opinion on Therapeutic Targets|March 20, 2020
An expert update on novel therapeutic targets for hyperphosphatemia in chronic kidney disease: preclinical and clinical innovationsMario Cozzolino, Markus Ketteler, Carsten Alexander Wagner
Pageof 22